Building on routinely collected health data for precision population care in inflammatory bowel disease
Postill G, Benchimol EI. Healthc Q. 2026; 29(2): 6-9.
Publications
The association between cirrhosis and outcomes among patients with lung cancer in Ontario between 2007 and 2017: a population-based study
Ho AK, Djerboua M, Chung W, Robinson A, Flemming JA. Can Liver J. 2026; 9(3): 450-463.
The sustainability and environmental impact of virtual care for inflammatory bowel disease: a population-based retrospective cohort study
Nguyen LJ, Huang V, Habashi P, McCormack D, Chong CA, Tandon P. J Can Assoc Gastroenterol. 2026; 9(5): 327-335.
The association between artificial light at night and inflammatory bowel disease incidence, surgery, and health services utilization: population-based observational studies
Kuenzig ME, Bernstein CN, Coward S, Dummer TJB, Elten M, Jones JL, Kaplan GG, Lavigne E, Murthy SK, Peña-Sánchez JN, Targownik LE, Li Z, Guan J, Tang F, Benchimol EI. Inflamm Bowel Dis. 2026; Jul 17 [Epub ahead of print].
Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis
McFarlane WJ, Flemming JA, Martinez-Cajas JL, Peng Y, Brogly SB. AIDS. 2026; 40(10): 1552-1560. Epub 2026 May 25.
Reimbursement restrictions reduce liver fibrosis screening in adults with diabetes in Ontario: a population-based interrupted time series analysis
Burnside J, Djerboua M, Flemming JA, Sebastiani G, Wong WWL, Lu Z, Bajaj HS, Patel K, Biondi M, Betel M, Nahwegahbow A, Greenwald ZR, Moodie EEM, Saeed S. Sci Rep. 2026; Apr 29. [Epub ahead of print].
Assessing the impact of delivery method on severe maternal morbidity among individuals with inflammatory bowel disease: a population-based study
Simpson AN, Sutradhar R, Benchimol EI, Chan WC, Porter JM, Moore S, Dossa F, Huang V, Maxwell C, Targownik L, Snelgrove JW, Liu N, Baxter NN. J Crohns Colitis. 2026; 20(4): jjag014.
Antibiotic and nonantibiotic drugs associated with Clostridioides difficile infection risk: a pharmacopoeia-wide case-cohort study
Brown KA, Coburn B, Hernandez A, Langford BJ, Leung V, MacFadden D, Rooney AM, Schwartz KL, Daneman N. J Infect Dis. 2026; Mar 14 [Epub ahead of print].
Patterns of specialist healthcare delivery among inflammatory bowel disease patients in response to the COVID-19 pandemic in Ontario: a population-based study
Nguyen LJ, Huang V, Habashi P, Gao Y, Tandon P. J Can Assoc Gastroenterol. 2026; 9(1): 24-29.
Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel disease cohort
Leung KK, Li W, Hansen B, Gulamhusein A, Lapointe-Shaw L, Ricciuto A, Benchimol EI, Flemming JA, Hirschfield GM. Hepatology. 2026; Feb 4 [Epub ahead of print].